Urologist Adam J. Gadzinski, MD, MS, shares how telemedicine can help improve access to urologic care.
In this video, Adam J. Gadzinski, MD, MS, discusses disparities in health care and how telemedicine can help mitigate them. Gadzinski is an acting instructor of urologic oncology at the Urology Clinic at the University of Washington Medical Center.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.